MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
Position Summary
As an Intern within Mirum’s Quality Compliance Team, you will support the development and implementation of data dashboards designed to monitor and enhance vendor compliance across GxP-regulated activities (GCP, GMP, GDP, GLP, GCLP and/or GVP as applicable). This internship offers a structured learning opportunity to gain exposure to pharmaceutical quality systems and vendor oversight processes within a regulated environment.
Under the guidance of Quality Compliance leadership, you will assist in gathering, organizing, and analyzing compliance data from internal systems and tracking tools to help build meaningful visual reports and dashboards. You will learn how key performance indicators (KPIs) are used to assess vendor performance, identify trends, and support proactive quality oversight. This role will provide hands-on experience in data organization, basic analytics, and quality reporting while contributing to ongoing compliance initiatives.
- This will be an 8-week assignment, 40 hours/week, paid internship
- Housing costs will not be reimbursed.
- Required to be on-site in Foster City, CA
Responsibilities And Main Tasks
- Complete training on GxP regulations, internal quality systems (such as Veeva QMS/QDOC), and relevant company procedures
- Work with the Quality Compliance team to understand how vendor performance is measured and tracked
- Help build and update data dashboards that monitor vendor compliance activities (such as Audit Status, Findings and Audit CAPAs)
- Review data to help identify trends, patterns, or potential compliance gaps
- Assist with gathering and organizing data from quality systems and tracking tools to ensure accuracy
- Support efforts to standardize and improve routine compliance reports
- Help prepare materials and reports that support inspection readiness activities
- Create simple documentation or user guides to explain how dashboards and reports are maintained
- Provide general project and administrative support to the Quality Compliance team as needed
Minimum Requirements
- Undergraduate or Graduate student in a scientific or related discipline.
- Proficiency in Microsoft Office applications (Excel required; advanced Excel skills preferred)
- Interest in data visualization tools (e.g., Power BI, Tableau, or similar platforms) preferred
Required Skills
- Passion to learn
- Ability to adopt urgent situations and accept ad hoc assignments
- Demonstrated ability to prioritize tasks and meet deadlines.
- Organized, responsible, resourceful, and detail-oriented
- Strong written and oral communication skills
- Ability to work effectively both independently and within a team.
Benefits For You
- Gain meaningful professional experience in GxP Quality Compliance and vendor oversight
- Gain cross-functional insight learning how to work within a global company
- Working in a friendly environment with a collaborative spirit
- Given an opportunity to improve personal growth and development
Please include your cover letter with your application outlining your desire to learn about this position. The pay for this role will be in the $35-45/hr range.
#LI-ONSITE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
Similar Jobs
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
